Filing Details
- Accession Number:
- 0001209191-10-038627
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-15 13:00:00
- Reporting Period:
- 2010-07-14
- Filing Date:
- 2010-07-15
- Accepted Time:
- 2010-07-15 15:17:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187573 | Judith Ogrady | 311 C Enterprise Drive Plainsboro NJ 08536 | Sr.vp Regulatory, Quality Assr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-07-14 | 1,540 | $32.02 | 37,135 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-07-14 | 1,540 | $37.18 | 35,595 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2010-07-14 | 770 | $0.00 | 770 | $32.02 |
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2010-07-14 | 770 | $0.00 | 770 | $32.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 770 | 2010-11-01 | No | 4 | M | Direct | |
| 0 | 2010-11-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $36.94 to $37.37.
- 25% of the shares vest on the first anniversary of the grant date of 11/01/2004 and the remaining 75% vest monthly thereafter over 36 months.
Billionaire Hedge Funds
